NEFL and myeloid sarcoma: More recently, Ioannides et al. (2021) confirmed higher CSF sTREM2 concentrations in MS patients compared to healthy controls, with positive associations observed between sTREM2, axonal injury markers (neurofilament light chain and phosphorylated neurofilament heavy chain), and disability scores such as EDSS and MSSS [23].